Bottle

May 20, 1976 - Warner-Lambert Company

Latest Warner-Lambert Company Patents:

COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Antibodies to M-CSF

Description

FIG. 1 is a front elevational view of a bottle showing my new design;

FIG. 2 is a top plan view; and

FIG. 3 is a bottom plan view.

Referenced Cited

U.S. Patent Documents

D196149	August 1963	Knies
D211683	July 1968	Johnson et al.
D236800	September 1975	Pardo

Patent History

Patent number: D247472
Type: Grant
Filed: May 20, 1976
Date of Patent: Mar 14, 1978
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: David S. Byrne (Atlantic Highlands, NJ)
Primary Examiner: Robert C. Spangler
Attorney: Albert H. Graddis
Application Number: 5/688,439

Classifications

Current U.S. Class: D/9111
International Classification: D0901;